Die Übersetzung dieser Seite ist experimentell und in Entwicklung. Wir freuen uns über Ihr !

Genpact Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

GenpactDer Gewinn des Unternehmens wird voraussichtlich um 6.3% pro Jahr sinken, während der Jahresumsatz voraussichtlich um 5.2% pro Jahr wachsen wird. Der Gewinn pro Aktie wird voraussichtlich sinken um 5.5% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 19.7% betragen.

Wichtige Informationen

-6.3%

Wachstumsrate der Gewinne

-5.5%

EPS-Wachstumsrate

Professional Services Gewinnwachstum	18.7%
Wachstumsrate der Einnahmen	5.2%
Zukünftige Eigenkapitalrendite	19.7%
Analystenabdeckung	Good
Zuletzt aktualisiert	21 May 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

An Intrinsic Calculation For Genpact Limited (NYSE:G) Suggests It's 28% Undervalued

Jul 27

Genpact's Recent Stock Decline Presents An Opportunity Amidst Capital Allocation Shift

Jul 18

Is It Too Late To Consider Buying Genpact Limited (NYSE:G)?

Jul 13

Does Genpact (NYSE:G) Have A Healthy Balance Sheet?

May 29

Genpact (NYSE:G) Is Looking To Continue Growing Its Returns On Capital

May 15

At US$45.77, Is It Time To Put Genpact Limited (NYSE:G) On Your Watch List?

Apr 14

Genpact Limited's (NYSE:G) Intrinsic Value Is Potentially 59% Above Its Share Price

Mar 31

Genpact raises quarterly dividend by 9.6% to $0.137/share

Feb 13

Returns At Genpact (NYSE:G) Appear To Be Weighed Down

Feb 13

When Should You Buy Genpact Limited (NYSE:G)?

Jan 12

We Think Genpact (NYSE:G) Can Stay On Top Of Its Debt

Dec 30

Genpact: A Solid Growing IT Player

Dec 20

Genpact Limited's (NYSE:G) Intrinsic Value Is Potentially 29% Above Its Share Price

Dec 02

Gewinn- und Umsatzwachstumsprognosen

NYSE:G - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	5,283	592	600	735	3
12/31/2025	4,887	516	527	641	12
12/31/2024	4,616	467	460	561	12
3/31/2024	4,519	642	429	499	N/A
12/31/2023	4,477	631	432	491	N/A
9/30/2023	4,433	430	473	529	N/A
6/30/2023	4,408	408	542	593	N/A
3/31/2023	4,392	363	474	524	N/A
12/31/2022	4,371	353	389	444	N/A
9/30/2022	4,341	337	401	461	N/A
6/30/2022	4,246	343	381	445	N/A
3/31/2022	4,145	374	442	503	N/A
12/31/2021	4,022	369	637	694	N/A
9/30/2021	3,901	371	547	607	N/A
6/30/2021	3,820	354	585	649	N/A
3/31/2021	3,732	314	610	680	N/A
12/31/2020	3,709	308	504	584	N/A
9/30/2020	3,700	315	428	512	N/A
6/30/2020	3,653	318	378	480	N/A
3/31/2020	3,635	330	304	415	N/A
12/31/2019	3,521	305	319	428	N/A
9/30/2019	3,415	302	324	478	N/A
6/30/2019	3,274	287	253	411	N/A
3/31/2019	3,121	278	202	361	N/A
12/31/2018	3,001	282	179	340	N/A
9/30/2018	2,900	270	194	298	N/A
6/30/2018	2,861	270	209	293	N/A
3/31/2018	2,803	274	224	301	N/A
12/31/2017	2,737	263	N/A	359	N/A
9/30/2017	2,684	272	N/A	373	N/A
6/30/2017	2,624	268	N/A	375	N/A
3/31/2017	2,584	264	N/A	386	N/A
12/31/2016	2,571	270	N/A	346	N/A
9/30/2016	2,536	258	N/A	310	N/A
6/30/2016	2,505	257	N/A	299	N/A
3/31/2016	2,484	254	N/A	294	N/A
12/31/2015	2,461	240	N/A	327	N/A
9/30/2015	2,416	221	N/A	347	N/A
6/30/2015	2,386	200	N/A	293	N/A
3/31/2015	2,338	186	N/A	282	N/A
12/31/2014	2,279	192	N/A	272	N/A
9/30/2014	2,236	195	N/A	257	N/A
6/30/2014	2,183	219	N/A	297	N/A
3/31/2014	2,156	234	N/A	294	N/A
12/31/2013	2,132	230	N/A	312	N/A
9/30/2013	2,081	234	N/A	334	N/A
6/30/2013	2,038	189	N/A	286	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: GFür die nächsten 3 Jahre wird ein Rückgang der Gewinne prognostiziert (-6.3% pro Jahr).

Ertrag vs. Markt: GFür die nächsten 3 Jahre wird ein Rückgang der Gewinne prognostiziert (-6.3% pro Jahr).

Hohe Wachstumserträge: GFür die nächsten 3 Jahre wird mit einem Rückgang der Erträge gerechnet.

Einnahmen vs. Markt: GDie Einnahmen des Unternehmens (5.2% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (8.4% pro Jahr).

Hohe Wachstumseinnahmen: GDie Einnahmen des Unternehmens (5.2% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: GDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (19.7 %).

Genpact Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Genpact Limited Provides Earnings Guidance for the Year Ending December 31, 2023

Price target decreased by 8.6% to US$43.30

Genpact Limited Provides Revenue Guidance for the Full Year 2023

Price target decreased by 7.4% to US$47.40

Genpact Limited Provides Revenue Guidance for 2023

Genpact Limited Provides Earnings Guidance for the Year 2023

Recent updates

Genpact: Modest Growth With Limited Upside Potential Ahead

First quarter 2024 earnings released: EPS: US$0.65 (vs US$0.58 in 1Q 2023)

Fourth quarter dividend of US$0.15 announced

Genpact Limited's (NYSE:G) Shares Lagging The Market But So Is The Business

Genpact Limited Declares Cash Dividend for the Second Quarter of 2024, Payable on June 26, 2024

The Return Trends At Genpact (NYSE:G) Look Promising

Genpact Limited to Report Q1, 2024 Results on May 09, 2024

Is Genpact Limited (NYSE:G) Potentially Undervalued?

Insufficient new directors

Genpact Limited, Annual General Meeting, May 02, 2024

Upcoming dividend of US$0.15 per share

These 4 Measures Indicate That Genpact (NYSE:G) Is Using Debt Safely

Genpact: A Steady Business With A Fast-Growing Dividend

Genpact's (NYSE:G) Upcoming Dividend Will Be Larger Than Last Year's

Full year 2023 earnings: EPS exceeds analyst expectations

Genpact Limited Announces Executive Appointments

Is There An Opportunity With Genpact Limited's (NYSE:G) 44% Undervaluation?

Senior VP notifies of intention to sell stock

Senior VP notifies of intention to sell stock

Senior VP notifies of intention to sell stock

Some Shareholders Feeling Restless Over Genpact Limited's (NYSE:G) P/E Ratio

Genpact Limited to Report Q4, 2023 Results on Feb 08, 2024

Genpact: AI And Cloud Likely To Drive Transformational Demand

Senior VP recently sold US$637k worth of stock

Genpact Strengthens Executive Team with Leadership Appointments for Investor Relations and Marketing

Senior VP notifies of intention to sell stock

Genpact Limited Announces Resignation of Kathryn Stein as Senior Vice President, Chief Strategy Officer and Global Business Leader, Enterprise Services and Analytics, Effective on January 12, 2024

Genpact (NYSE:G) Is Experiencing Growth In Returns On Capital

Upcoming dividend of US$0.14 per share at 1.6% yield

Genpact Unveils Playbook: FMOps – Generative AI Imperative for Production for Scaling Responsible Generative AI Projects

Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Genpact Announces Chief Executive Officer Changes

Genpact Limited Provides Earnings Guidance for the Year Ending December 31, 2023

Genpact Limited Declares Cash Dividend for the Fourth Quarter of 2023, Payable on December 22, 2023

Genpact: Resilient Business Model That Can Continue To Grow At Historical Rate

Is Genpact Limited (NYSE:G) Potentially Undervalued?

Genpact: Stable Company But Macroeconomic Uncertainties Linger

Genpact Limited to Report Q3, 2023 Results on Nov 08, 2023

Is Genpact (NYSE:G) Using Too Much Debt?

Upcoming dividend of US$0.14 per share at 1.5% yield

Genpact (NYSE:G) Is Doing The Right Things To Multiply Its Share Price

Price target decreased by 8.6% to US$43.30

Genpact Limited Provides Revenue Guidance for the Full Year 2023

New minor risk - Dividend sustainability

An Intrinsic Calculation For Genpact Limited (NYSE:G) Suggests It's 28% Undervalued

Genpact's Recent Stock Decline Presents An Opportunity Amidst Capital Allocation Shift

Genpact Limited Declares Cash Dividend for the Third Quarter of 2023, Payable on September 26, 2023

Is It Too Late To Consider Buying Genpact Limited (NYSE:G)?

Genpact Limited to Report Q2, 2023 Results on Aug 09, 2023

Genpact Limited to Report Q2, 2023 Results on Aug 09, 2023

Genpact Limited(NYSE:G) dropped from Russell 1000 Dynamic Index

Insider recently sold US$1.2m worth of stock

Insider notifies of intention to sell stock

Insufficient new directors

Upcoming dividend of US$0.14 per share at 1.5% yield

Does Genpact (NYSE:G) Have A Healthy Balance Sheet?

Hindustan Unilever Limited and Genpact Launch Be.Seen to Scale Minority-Owned Businesses in India

President notifies of intention to sell stock

Independent Director recently bought US$185k worth of stock

Price target decreased by 7.4% to US$47.40

Genpact (NYSE:G) Is Looking To Continue Growing Its Returns On Capital

Genpact Limited Provides Revenue Guidance for 2023

First quarter 2023 earnings: EPS exceeds analyst expectations

President exercised options and sold US$2.5m worth of stock

At US$45.77, Is It Time To Put Genpact Limited (NYSE:G) On Your Watch List?

President notifies of intention to sell stock

Genpact Limited's (NYSE:G) Intrinsic Value Is Potentially 59% Above Its Share Price

Insider notifies of intention to sell stock

President exercised options and sold US$4.2m worth of stock